Skip to main content

previous disabled Page of 26
and
  1. Article

    Open Access

    Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study

    Most gastrointestinal stromal tumors (GISTs) harbor c-KIT or PDGFRA mutations. Administration of tyrosine kinase inhibitors (TKIs) has significantly improved the survival of patients with GISTs. We aimed to evalu...

    Hui-Jen Tsai, Yan-Shen Shan, Ching-Yao Yang, Chin-Fu Hsiao, Chung-Hsin Tsai in BMC Cancer (2024)

  2. Article

    Open Access

    TCBIR/CD320: a potential therapeutic target upregulated in endothelial cells and associated with immune cell infiltration in liver hepatocellular carcinoma

    CD320, which is a transmembrane protein responsible for facilitating the absorption of vitamin B12, plays a key role in this process. However, the relationships between CD320 and immune cell infiltration level...

    Shubin Zhang, Zhongyi Jiang, Pusen Wang, Weihao Jiang, Wei Ding in Discover Oncology (2024)

  3. Article

    Open Access

    Exome sequencing and genome-wide association analyses unveils the genetic predisposition in hydroxychloroquine retinopathy

    To unveil the candidate susceptibility genes in chloroquine/hydroxychloroquine (CQ/HCQ) retinopathy using whole exome sequencing (WES) and genome-wide association study (GWAS).

    Hsun-I Chiu, Hui-Chen Cheng, Chih-Chiau Wu, Shih-Jen Chen, De-Kuang Hwang in Eye (2024)

  4. No Access

    Article

    Early Contrast-Enhanced MR for Diagnosing Complete Tumor Response of Locally Advanced Esophageal Squamous Cell Carcinoma After Neoadjuvant Therapy: A Retrospective Comparative Study

    This study assessed the performance of early contrast-enhanced magnetic resonance (ECE-MR) in the detecting of complete tumor response (ypT0) in patients with esophageal squamous cell carcinoma following neoad...

    Yan-Jie Shi MD, Shuo Yan MD, **n Yang MD, Zhen Guan MD in Annals of Surgical Oncology (2024)

  5. Article

    Open Access

    Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement

    High-grade B-cell lymphoma (HGBCL), the subtype of non-Hodgkin lymphoma, to be relapsed or refractory in patients after initial therapy or salvage chemotherapy. Dual dysregulation of MYC and BCL2 is one of the...

    Lin Liu, Wenbin Mo, Miao Chen, Yi Qu, **** Wang, Ying Liang, **ao**g Yan in BMC Cancer (2024)

  6. Article

    Open Access

    Targeting IL-11R/EZH2 signaling axis as a therapeutic strategy for osteosarcoma lung metastases

    Lung metastases are the primary cause of death for osteosarcoma (OS) patients. We recently validated interleukin-11 receptor α (IL-11Rα) as a molecular target for the inhibition of OS lung metastases. Since th...

    Eswaran Devarajan, R. Eric Davis, Hannah C. Beird, Wei-Lien Wang in Discover Oncology (2024)

  7. Article

    Open Access

    In situ HER2 RNA expression as a predictor of pathologic complete response of HER2-positive breast cancer patients receiving neoadjuvant chemotherapy and anti-HER2 targeted treatment

    Immunohistochemistry (IHC) and in situ hybridization (ISH) remain standard biomarkers for therapeutic decisions in human epidermal growth factor 2 (HER2)-positive breast cancers (BCs); however, they are insuff...

    Huang-Chun Lien, Chiao Lo, Yi-Hsuang Lee, Po-Hang Lin in Breast Cancer Research (2024)

  8. No Access

    Article

    Heparan sulfate acts as an activator of the NLRP3 inflammasome promoting inflammatory response in the development of acute pancreatitis

    Accumulating evidence has shown that the NOD-like receptor protein 3 (NLRP3) inflammasome plays a crucial role in the inflammatory cascades involved in the development of acute pancreatitis (AP). However, the ...

    Li-Jun Zhao, Peng Chen, Ling Huang, Wen-Qi He, Ying-Rui Tang in Journal of Gastroenterology (2024)

  9. Article

    Open Access

    Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma

    Although sorafenib has been consistently used as a first-line treatment for advanced hepatocellular carcinoma (HCC), most patients will develop resistance, and the mechanism of resistance to sorafenib needs fu...

    Hong **ao, Hangyu Chen, Lei Zhang in World Journal of Surgical Oncology (2024)

  10. Article

    Open Access

    Exploring the therapeutic mechanisms of Coptidis Rhizoma in gastric precancerous lesions: a network pharmacology approach

    Gastric precancerous lesions are a critical stage in the development of gastric cancer or gastric adenocarcinoma, and their outcome plays an important role in the malignant progression of gastric cancer. Copti...

    Xuxing Ye, Chao Yang, Hanzhi Xu, Qin He, Lin Sheng, Junmei Lin in Discover Oncology (2024)

  11. Article

    Open Access

    Characteristics of mast cell infiltration in lung adenocarcinoma and its impact on prognosis

    The role of mast cells in malignancies remains unclear, and there is no clear correlation between mast cells and tumor microvessels, tumor growth, or lung adenocarcinoma (LUAD) prognosis. This study aims to ex...

    Zijian Qiu, Guanchao Pang, **a Xu, Jun Lin, **li Wang in Discover Oncology (2024)

  12. Article

    Open Access

    Immunotherapy combined with apatinib in the treatment of advanced or metastatic gastric/gastroesophageal tumors: a systematic review and meta-analysis

    Immunotherapy or apatinib alone has been used as third-line adjuvant therapy for advanced or metastatic gastric/gastroesophageal junction (G/GEJ) tumors, but the efficacy of combining them with each other for ...

    **cheng Wang, Jie Lin, Ruimin Wang, Ti Tong, Yinghao Zhao in BMC Cancer (2024)

  13. Article

    Open Access

    Proteogenomic characterization of difficult-to-treat breast cancer with tumor cells enriched through laser microdissection

    Breast cancer (BC) is the most commonly diagnosed cancer and the leading cause of cancer death among women globally. Despite advances, there is considerable variation in clinical outcomes for patients with non...

    Praveen-Kumar Raj-Kumar, **aoying Lin, Tao Liu, Lori A. Sturtz in Breast Cancer Research (2024)

  14. Article

    Open Access

    METTL14 regulates CD8+T-cell activation and immune responses to anti‐PD‐1 therapy in lung cancer

    N6-methyladenosine (m6A) modification plays an important role in lung cancer. However, methyltransferase-like 14 (METTL14), which serves as the main component of the m6A complex, has been less reported to be i...

    Chongqi Sun, Jian Wang, Huixing Li, Luyao Liu, Yu Lin in World Journal of Surgical Oncology (2024)

  15. No Access

    Article

    Long-term oncological outcomes of 3D versus 2D laparoscopic gastrectomy for gastric cancer: a randomized clinical trial

    Laparoscopy-assisted gastrectomy (LG) is rapidly gaining popularity owing to its minimal invasiveness. Previous studies have found that compared with two-dimensional (2D)-LG, three-dimensional (3D)-LG showed b...

    Qing Zhong, Jun-Yu Chen, Zhi-**n Shang-Guan, Zhi-Yu Liu, Guang-Tan Lin in Gastric Cancer (2024)

  16. No Access

    Article

    Correlation of contrast sensitivity with ganglion cell/inner plexiform layer thickness and damage location in glaucoma with varying severity

    To investigate the correlation of contrast sensitivity with macular region ganglion cell/inner plexiform layer (GC/IPL) thickness and damage location in open-angle glaucoma (OAG) of varying severity.

    Ruiqi Pang, Jieting Peng, Qing Zhang, Kai Cao, Zhong-Lin Lu, Ningli Wang in Eye (2024)

  17. No Access

    Article

    Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study

    Combination treatment with transcatheter arterial chemoembolization (TACE), lenvatinib, and anti-programmed death-1 (anti-PD-1) antibodies (triple therapy) has a high rate of tumor response and converted resec...

    Jun-Yi Wu MD, PhD, Jia-Yi Wu MD, Yang-Kai Fu MD in Annals of Surgical Oncology (2024)

  18. Article

    Open Access

    Prognostic and predictive value of tumor deposits in advanced signet ring cell colorectal cancer: SEER database analysis and multicenter validation

    Colorectal signet-ring cell carcinoma (SRCC) is a rare cancer with a bleak prognosis. The relationship between its clinicopathological features and survival remains incompletely elucidated. Tumor deposits (TD)...

    Fuchao Li, Lei Liu, Qingzhao Feng, **aohong Wang in World Journal of Surgical Oncology (2024)

  19. Article

    Open Access

    Ferroptosis-related lncRNA NRAV affects the prognosis of hepatocellular carcinoma via the miR-375-3P/SLC7A11 axis

    Ferroptosis has important value in cancer treatment. It is significant to explore the new ferroptosis-related lncRNAs prediction model in Hepatocellular carcinoma (HCC) and the potential molecular mechanism of...

    Ke Zong, Caifeng Lin, Kai Luo, Yilei Deng, Hongfei Wang, Jianfei Hu, Shi Chen in BMC Cancer (2024)

  20. No Access

    Article

    Comparison of Short-Term Outcomes After Robotic Versus Laparoscopic Radical Gastrectomy for Advanced Gastric Cancer in Elderly Individuals: A Propensity Score-Matching Study

    Robotic gastrectomy (RG) has been widely used to treat gastric cancer. However, whether the short-term outcomes of robotic gastrectomy are superior to those of laparoscopic gastrectomy (LG) for elderly patient...

    Zhi-Wei Zheng MD, Mi Lin MD, Hua-Long Zheng MD in Annals of Surgical Oncology (2024)

previous disabled Page of 26